HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Shuichi Hanada Selected Research
Shuichi Hanada Research Topics
Disease
8
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2015 - 02/2002
3
Lymphoma (Lymphomas)
01/2018 - 02/2002
3
B-Cell Lymphoma (Lymphoma, B Cell)
12/2017 - 12/2008
2
Neoplasms (Cancer)
12/2015 - 03/2009
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2015 - 01/2007
2
Neutropenia
12/2007 - 02/2002
2
Thrombocytopenia (Thrombopenia)
12/2007 - 02/2002
2
T-Cell Leukemia (Leukemia, T Cell)
05/2002 - 04/2002
1
Hepatocellular Carcinoma (Hepatoma)
06/2020
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2019
1
Wilms Tumor (Wilm's Tumor)
01/2019
1
Hypersensitivity (Allergy)
01/2019
1
Lymphadenopathy
01/2017
1
Chromosome Aberrations (Chromosome Abnormalities)
01/2015
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2013
1
T-Cell Lymphoma (Lymphoma, T Cell)
01/2013
1
Anemia
10/2012
1
Multiple Myeloma
10/2012
1
Renal Insufficiency (Renal Failure)
10/2012
1
Pulmonary Embolism
01/2012
1
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
03/2010
1
Infections
12/2007
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2007
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
08/2007
1
Leukemia
05/2003
1
Acute Promyelocytic Leukemia
05/2002
1
Body Weight (Weight, Body)
02/2002
Drug/Important Bio-Agent (IBA)
3
Rituximab (Mabthera)
FDA Link
12/2017 - 12/2008
2
mogamulizumab
IBA
01/2018 - 03/2010
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
09/2007 - 02/2002
1
Vaccines
IBA
01/2019
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2019
1
Peptides (Polypeptides)
IBA
01/2019
1
Interleukin-2 Receptors (IL 2 Receptor)
IBA
01/2017
1
Podophyllotoxin (Condylox)
FDA Link
Generic
01/2015
1
Anthracyclines
IBA
01/2015
1
Alkylating Agents
IBA
01/2015
1
Hepcidins
IBA
10/2012
1
Creatinine
IBA
10/2012
1
Iron
IBA
10/2012
1
Anticoagulants
IBA
01/2012
1
Antigens
IBA
03/2009
1
ranimustine
IBA
12/2007
1
Adenosine Monophosphate (AMP)
IBA
12/2007
1
Prednisone (Sone)
FDA Link
Generic
12/2007
1
Etoposide (VP 16)
FDA Link
Generic
12/2007
1
Doxorubicin (Adriamycin)
FDA Link
Generic
12/2007
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2007
1
Vincristine (Oncovin)
FDA Link
Generic
12/2007
1
Vindesine (Vindesin)
IBA
12/2007
1
Carboplatin (JM8)
FDA Link
Generic
12/2007
1
Cladribine
FDA Link
Generic
08/2007
1
Interleukin-7 (Interleukin 7)
IBA
05/2003
1
Arsenic Trioxide (Trisenox)
FDA Link
05/2002
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
05/2002
1
Caspases
IBA
05/2002
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
04/2002
1
PAK 200
IBA
04/2002
1
Exotoxins
IBA
04/2002
1
Immunotoxins (Immunotoxin)
IBA
04/2002
1
B3(Fv)-PE38KDEL recombinant immunotoxin
IBA
04/2002
1
Tacrolimus (Prograf)
FDA Link
Generic
04/2002
1
Proteins (Proteins, Gene)
FDA Link
04/2002
1
Monoclonal Antibodies
IBA
04/2002
1
Quinidine (Chinidin)
FDA Link
Generic
04/2002
1
cepharanthine
IBA
04/2002
1
Thrombopoietin (c-mpl Ligand)
IBA
02/2002
Therapy/Procedure
6
Therapeutics
01/2019 - 02/2002
5
Drug Therapy (Chemotherapy)
01/2019 - 02/2002
2
Combination Drug Therapy (Combination Chemotherapy)
12/2015 - 01/2015
1
Hepatectomy
06/2020
1
Blood Transfusion (Blood Transfusions)
06/2020
1
Hematopoietic Stem Cell Transplantation
12/2015
1
Remission Induction
12/2008
1
Stem Cell Transplantation
09/2007